Analyst Research

Report Title Price
Provider: Thomson Reuters Stock Report
$25.00
Provider: Reuters Investment Profile
$20.00
Provider: GlobalData
$250.00
Provider: GlobalData
$125.00

NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.

Biosign Technologies Inc acquires 51 pct of Meck Medical GmbH


Thursday, 19 Jun 2014 05:05pm EDT 

Biosign Technologies Inc:Says execution of Share Purchase Agreement (SPA) under which it has agreed to acquire 51 pct of issued and outstanding shares of Klingenberg Germany-based MECK Medical GmbH.Purchase price will be satisfied with cash payment of 875,000 euros, and by issuance of 3,000,000 common shares of Biosign at an ascribed price of $0.05 per share, being premium to the market price at the execution date of the SPA.This transaction is subject to receipt of all necessary regulatory and government approvals.Common shares to be issued to the vendor in connection with this transaction will be subject to a regulatory hold period of 4 months and 1 day. 

Company Quote

0.02
0.0 +0.00%
25 Jul 2014